U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07294235) titled 'A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants' on Dec. 07.
Brief Summary: The purpose of this study is to evaluate the tolerability , safety and pharmacodynamics of BGM1812 administered subcutaneously in healthy and non-diabetic overweight or obese Chinese participants, and to investigate the pharmacokinetic profile of BGM1812 in the bloodstream.
Study Start Date: Dec. 05
Study Type: INTERVENTIONAL
Condition:
Overweight or Obesity
Intervention:
DRUG: BGM1812
AdministeredSC
DRUG: Placebo
Administered SC
DRUG: BGM1812
Administered SC
DRUG: Placebo
Administered SC
Recrui...